118 related articles for article (PubMed ID: 34474820)
1. Multifunctional silica-coated mixed polymeric micelles for integrin-targeted therapy of pediatric patient-derived glioblastoma.
Chauhan PS; Kumarasamy M; Carcaboso AM; Sosnik A; Danino D
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112261. PubMed ID: 34474820
[TBL] [Abstract][Full Text] [Related]
2. cRGD peptide-installed epirubicin-loaded polymeric micelles for effective targeted therapy against brain tumors.
Quader S; Liu X; Chen Y; Mi P; Chida T; Ishii T; Miura Y; Nishiyama N; Cabral H; Kataoka K
J Control Release; 2017 Jul; 258():56-66. PubMed ID: 28483513
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
5. Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation.
Bonde GV; Ajmal G; Yadav SK; Mittal P; Singh J; Bakde BV; Mishra B
Colloids Surf B Biointerfaces; 2020 Jan; 185():110611. PubMed ID: 31704609
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of functionalized chitosan-Pluronic micelles loaded with myricetin on glioblastoma cancer.
Wang G; Wang JJ; Tang XJ; Du L; Li F
Nanomedicine; 2016 Jul; 12(5):1263-78. PubMed ID: 26970027
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
Li AJ; Zheng YH; Liu GD; Liu WS; Cao PC; Bu ZF
Mol Med Rep; 2015 Apr; 11(4):3078-86. PubMed ID: 25434368
[TBL] [Abstract][Full Text] [Related]
8. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles.
Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z
Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871
[TBL] [Abstract][Full Text] [Related]
9. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme.
Kanamori M; Vanden Berg SR; Bergers G; Berger MS; Pieper RO
Cancer Res; 2004 Apr; 64(8):2751-8. PubMed ID: 15087390
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
11. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
[TBL] [Abstract][Full Text] [Related]
12. Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.
Chatterjee S; Matsumura A; Schradermeier J; Gillespie GY
J Neurooncol; 2000; 46(2):135-44. PubMed ID: 10894366
[TBL] [Abstract][Full Text] [Related]
13. Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma.
Vikram ; Kumar S; Ali J; Baboota S
Assay Drug Dev Technol; 2024; 22(2):73-85. PubMed ID: 38193798
[No Abstract] [Full Text] [Related]
14. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
15. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
16. Small, Smart, and LDLR-Specific Micelles Augment Sorafenib Therapy of Glioblastoma.
Wei J; Xia Y; Meng F; Ni D; Qiu X; Zhong Z
Biomacromolecules; 2021 Nov; 22(11):4814-4822. PubMed ID: 34677048
[TBL] [Abstract][Full Text] [Related]
17. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
18. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
[TBL] [Abstract][Full Text] [Related]
19. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
Chen W; Zou Y; Zhong Z; Haag R
Small; 2017 Feb; 13(6):. PubMed ID: 27865044
[TBL] [Abstract][Full Text] [Related]
20. Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub-5 Ultrafine Iron Oxide Nanoparticles.
Li Y; Xie M; Jones JB; Zhang Z; Wang Z; Dang T; Wang X; Lipowska M; Mao H
Adv Healthc Mater; 2022 Jul; 11(14):e2102816. PubMed ID: 35481625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
